CHE - Chemed Corporation

NYSE - Nasdaq Real Time Price. Currency in USD
331.76
+0.10 (+0.03%)
As of 2:02PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close331.66
Open332.93
Bid331.77 x 1800
Ask332.54 x 800
Day's Range330.50 - 333.50
52 Week Range260.03 - 341.18
Volume51,550
Avg. Volume121,723
Market Cap5.288B
Beta (3Y Monthly)0.91
PE Ratio (TTM)27.02
EPS (TTM)12.28
Earnings DateJul 23, 2019 - Jul 29, 2019
Forward Dividend & Yield1.20 (0.37%)
Ex-Dividend Date2019-05-29
1y Target Est359.00
Trade prices are not sourced from all markets
  • Here's Why I Think Chemed (NYSE:CHE) Might Deserve Your Attention Today
    Simply Wall St.2 days ago

    Here's Why I Think Chemed (NYSE:CHE) Might Deserve Your Attention Today

    For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

  • Markit3 days ago

    See what the IHS Markit Score report has to say about Chemed Corp.

    Chemed Corp NYSE:CHEView full report here! Summary * Bearish sentiment is low * Economic output in this company's sector is expanding Bearish sentimentShort interest | PositiveShort interest is extremely low for CHE with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting CHE. Money flowETF/Index ownership | NeutralETF activity is neutral. The net inflows of $2.58 billion over the last one-month into ETFs that hold CHE are not among the highest of the last year and have been slowing. Economic sentimentPMI by IHS Markit | PositiveAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Consumer Services sector is rising. The rate of growth is strong relative to the trend shown over the past year. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Business Wire4 days ago

    Chemed Corporation Holds Annual Meeting of Shareholders; Board Declares Quarterly Dividend

    Shareholders of Chemed Corporation (CHE) today elected a slate of 10 directors at the Company’s 2019 annual shareholders’ meeting. Shareholders ratified the continuation of PricewaterhouseCoopers LLP as the Company’s independent accountants for 2019 and approved Chemed’s executive compensation. In addition, shareholders voted in favor of management’s recommendation to reject the shareholder proposal requesting a semi-annual report on the Company’s policies on political spending and political contributions made.

  • Business Wire10 days ago

    Chemed Corporation to Present at the 2019 RBC Capital Markets Global Healthcare Conference

    Chemed Corporation (CHE) today announced that it will deliver a presentation at the RBC Capital Markets Global Healthcare Conference on Tuesday, May 21, 2019, at approximately 11:00 a.m. (ET) at The InterContinental New York Barclay Hotel in New York City. The audio webcast can be accessed by visiting the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours after the live presentation and will be accessible for 90 days.

  • Business Wire16 days ago

    Chemed Corporation to Present at the Bank of America Merrill Lynch 2019 Health Care Conference

    Chemed Corporation (CHE) today announced that it will deliver a presentation at the Bank of America Merrill Lynch 2019 Health Care Conference on Tuesday, May 14, 2019, at 3:00 PM (PDT) at the Encore at the Wynn Las Vegas. The presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours of the live presentation and will be accessible for 90 days.

  • Thomson Reuters StreetEvents22 days ago

    Edited Transcript of CHE earnings conference call or presentation 30-Apr-19 2:00pm GMT

    Q1 2019 Chemed Corp Earnings Call

  • Why You Should Like Chemed Corporation’s (NYSE:CHE) ROCE
    Simply Wall St.22 days ago

    Why You Should Like Chemed Corporation’s (NYSE:CHE) ROCE

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Today we'll look at Chemed Corporation (NYSE:CHE) and reflect on its potential as an investment. Spec...

  • Chemed Corp (CHE) Q1 2019 Earnings Call Transcript
    Motley Fool24 days ago

    Chemed Corp (CHE) Q1 2019 Earnings Call Transcript

    CHE earnings call for the period ending March 31, 2019.

  • Chemed (CHE) Q1 Earnings Miss Estimates, Revenues Grow Y/Y
    Zacks24 days ago

    Chemed (CHE) Q1 Earnings Miss Estimates, Revenues Grow Y/Y

    Despite several downsides, Chemed (CHE) witnesses solid revenue growth across key subsidiaries - VITAS and Roto-Rooter.

  • Associated Press25 days ago

    Chemed: 1Q Earnings Snapshot

    On a per-share basis, the Cincinnati-based company said it had profit of $2.70. Earnings, adjusted for one-time gains and costs, came to $2.92 per share. The operator of the Roto-Rooter plumbing service ...

  • Business Wire25 days ago

    Chemed Reports First-Quarter 2019 Results

    Chemed Corporation , which operates VITAS Healthcare Corporation , one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation

  • DGX vs. CHE: Which Stock Is the Better Value Option?
    Zacks28 days ago

    DGX vs. CHE: Which Stock Is the Better Value Option?

    DGX vs. CHE: Which Stock Is the Better Value Option?

  • Here’s What Hedge Funds Think About Chemed Corporation (CHE)
    Insider Monkeylast month

    Here’s What Hedge Funds Think About Chemed Corporation (CHE)

    World-class money managers like Ken Griffin and Barry Rosenstein only invest their wealthy clients' money after undertaking a rigorous examination of any potential stock. They are particularly successful in this regard when it comes to small-cap stocks, which their peerless research gives them a big information advantage on when it comes to judging their worth. […]

  • Here's Why You Should Invest in Chemed (CHE) Stock Right Now
    Zackslast month

    Here's Why You Should Invest in Chemed (CHE) Stock Right Now

    Chemed (CHE) is expected to benefit from the launch of its VITAS Healthcare Inpatient Hospice Unit.

  • Here's Why You Should Hold on to DaVita (DVA) Stock Now
    Zackslast month

    Here's Why You Should Hold on to DaVita (DVA) Stock Now

    DaVita (DVA) is gaining steadily from expansion in international markets, strong demand in dialysis services and prudent acquisitions. However, rising expenses remain a dampener.

  • Does Chemed Corporation's (NYSE:CHE) CEO Salary Compare Well With Others?
    Simply Wall St.2 months ago

    Does Chemed Corporation's (NYSE:CHE) CEO Salary Compare Well With Others?

    Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! Kevin McNamara became the CEO of Chemed Corporation (NYSE:CHE) in 2001. This report will, first, examine the CEO c...

  • Business Wire2 months ago

    Chemed To Report First-Quarter 2019 Earnings April 29, Related Conference Call To Be Held On April 30

    Chemed Corporation (CHE) today announced that it will release financial results for the first quarter ended March 31, 2019, on Monday, April 29, 2019, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Tuesday, April 30, 2019, to discuss the company's quarterly results and to provide an update on its business. The toll-free dial-in number for the conference call is 844-743-2500 for U.S. and Canadian participants and +1 661-378-9533 for international participants.

  • Zacks.com featured expert Kevin Matras highlights: Methode Electronics, Walker & Dunlop, Marker Therapeutics, Chemed and Olympic Steel
    Zacks2 months ago

    Zacks.com featured expert Kevin Matras highlights: Methode Electronics, Walker & Dunlop, Marker Therapeutics, Chemed and Olympic Steel

    Zacks.com featured expert Kevin Matras highlights: Methode Electronics, Walker & Dunlop, Marker Therapeutics, Chemed and Olympic Steel

  • These 5 Stocks Make Great Buys on New Analyst Coverage
    Zacks2 months ago

    These 5 Stocks Make Great Buys on New Analyst Coverage

    Increased analyst coverage over the last few weeks might lead to solid price appreciation for these stocks.

  • Why Is Chemed (CHE) Up 2.7% Since Last Earnings Report?
    Zacks2 months ago

    Why Is Chemed (CHE) Up 2.7% Since Last Earnings Report?

    Chemed (CHE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • When Should You Buy Chemed Corporation (NYSE:CHE)?
    Simply Wall St.2 months ago

    When Should You Buy Chemed Corporation (NYSE:CHE)?

    Chemed Corporation (NYSE:CHE), which is in the healthcare business, and is based in United States, saw a significant share price rise of over 20% in the past couple of monthsRead More...

  • Chemed (CHE) Upgraded to Strong Buy: What Does It Mean for the Stock?
    Zacks2 months ago

    Chemed (CHE) Upgraded to Strong Buy: What Does It Mean for the Stock?

    Chemed (CHE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 1 (Strong Buy).